Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Supreme Well Investments Limited is a private investment holding company that serves as a primary vehicle for Dr. Ge Li's ownership interests in the WuXi AppTec group. As a major shareholder in both WuXi AppTec and WuXi Biologics, the company is a central entity in the corporate structure of one of the world's largest healthcare service platforms. The underlying businesses supported by Supreme Well Investments provide comprehensive R&D and manufacturing services across small molecules, biologics, and advanced therapies. While the company does not maintain an internal drug pipeline, its strategic holdings are vital to the operations of the global pharmaceutical supply chain. It is incorporated in the British Virgin Islands and operates as a private entity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Supreme Well Investments.